AbbVie (ABBV) Inks CAR T Deal, Gets Botox Label Expansion Nod

AbbVie ABBV announced that it has inked a collaboration and license agreement with privately-held CRISPR editing company, Caribou Biosciences, to develop new chimeric antigen receptor (CAR)-T cell …
( read original story …)


Advertisement